novo nordisk glp-1 receptor agonist medications vs Eli Lilly: Who's Winning the Obesity Drug Race? Oral GLP-1 receptor agonist Rybelsus

Lancet Diabetes & Endocrinology, 2025 Heart & blood markers Blood pressure and blood-fat readings, tracked as extra measurements across the Phase 2 trials

Stanley TL et al

Efficacy and Safety of Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron for Glycemic Control Among Patients With Type 2 Diabetes

Both peptides stimulate your pituitary gland to release more growth hormone

Metabolic regulation of type I interferon production

When the body's reserves of this crucial compound are depleteda phenomenon heavily documented in both Long COVID and ME/CFSthe resulting cellular damage can drive profound fatigue, brain fog, and immune dysfunction